Tesaro Adds Runway By Out-licensing Niraparib In Prostate Cancer

 
• By Joseph Haas
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas